Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine on the Pharmacokinetics of Atazanavir in HIV-Infected Subjects Receiving Atazanavir With Ritonavir and Tenofovir.

Trial Profile

Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine on the Pharmacokinetics of Atazanavir in HIV-Infected Subjects Receiving Atazanavir With Ritonavir and Tenofovir.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Aug 2012

At a glance

  • Drugs Atazanavir; Famotidine; Nucleoside reverse transcriptase inhibitors; Ritonavir; Tenofovir
  • Indications Gastro-oesophageal reflux; HIV infections; Peptic ulcer
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 06 Jul 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
    • 06 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top